GlobeNewswire Inc.··UnknownUnnatural Products Lands $45M Series B, Novartis Deal Worth $1.7B
Biotech startup Unnatural Products secures $45M Series B funding led by The Venture Collective and inks $1.7B milestone deal with Novartis for oral peptide therapeutics.
MRKARGXNVSmacrocyclic peptidesSeries B funding